Literature DB >> 23494487

Highlights from the fifth international symposium of thrombosis and anticoagulation (ISTA V), October 18-19, 2012, Belo Horizonte, Minas Gerais, Brazil.

Renato D Lopes1, Richard C Becker, L Kristin Newby, Eric D Peterson, Elaine M Hylek, Robert Giugliano, Christopher B Granger, Kenneth W Mahaffey, Antonio C Carvalho, Otavio Berwanger, Roberto R Giraldez, Gilson Soares Feitosa-Filho, Marcia M Barbosa, Maria da Consolacao V Moreira, Renato A K Kalil, Marildes Freitas, Joao Carlos de Campos Guerra, Marcio Vinicius Lins Barros, Thiago da Rocha Rodrigues, Antonio C Lopes, David A Garcia.   

Abstract

To discuss and share knowledge about advances in the care of patients with thrombotic disorders, the Fifth International Symposium of Thrombosis and Anticoagulation was held in Belo Horizonte, Minas Gerais, Brazil, on October 18-19, 2012. This scientific program was developed by clinicians for clinicians and was promoted by three major clinical research institutes: the Brazilian Clinical Research Institute, the Duke Clinical Research Institute of the Duke University School of Medicine, and Hospital do Coração Research Institute. Comprising 2 days of academic presentations and open discussion, the symposium had as its primary goal to educate, motivate, and inspire internists, cardiologists, hematologists, and other physicians by convening national and international visionaries, thought-leaders, and dedicated clinician-scientists. This paper summarizes the symposium proceedings.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23494487     DOI: 10.1007/s11239-013-0906-z

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  100 in total

1.  Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients.

Authors:  Samuel Z Goldhaber; Alain Leizorovicz; Ajay K Kakkar; Sylvia K Haas; Geno Merli; Robert M Knabb; Jeffrey I Weitz
Journal:  N Engl J Med       Date:  2011-11-13       Impact factor: 91.245

2.  Eplerenone and atrial fibrillation in mild systolic heart failure: results from the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure) study.

Authors:  Karl Swedberg; Faiez Zannad; John J V McMurray; Henry Krum; Dirk J van Veldhuisen; Harry Shi; John Vincent; Bertram Pitt
Journal:  J Am Coll Cardiol       Date:  2012-05-01       Impact factor: 24.094

3.  A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score.

Authors:  S Barbar; F Noventa; V Rossetto; A Ferrari; B Brandolin; M Perlati; E De Bon; D Tormene; A Pagnan; P Prandoni
Journal:  J Thromb Haemost       Date:  2010-11       Impact factor: 5.824

4.  A risk score to predict bleeding in patients with acute coronary syndromes.

Authors:  Roxana Mehran; Stuart J Pocock; Eugenia Nikolsky; Tim Clayton; George D Dangas; Ajay J Kirtane; Helen Parise; Martin Fahy; Steven V Manoukian; Frederick Feit; Magnus E Ohman; Bernard Witzenbichler; Giulio Guagliumi; Alexandra J Lansky; Gregg W Stone
Journal:  J Am Coll Cardiol       Date:  2010-06-08       Impact factor: 24.094

5.  Antithrombotic strategy in non-ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention: insights from the ACTION (Acute Coronary Treatment and Intervention Outcomes Network) Registry.

Authors:  Renato D Lopes; Eric D Peterson; Anita Y Chen; Matthew T Roe; Tracy Y Wang; E Magnus Ohman; David J Magid; P Michael Ho; Stephen D Wiviott; Benjamin M Scirica; Karen P Alexander
Journal:  JACC Cardiovasc Interv       Date:  2010-06       Impact factor: 11.195

Review 6.  Heparin-induced thrombocytopenia. A contemporary clinical approach to diagnosis and management.

Authors:  Eduard Shantsila; Gregory Y H Lip; Beng H Chong
Journal:  Chest       Date:  2009-06       Impact factor: 9.410

7.  Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study.

Authors:  Thomas J Wang; Martin G Larson; Daniel Levy; Ramachandran S Vasan; Eric P Leip; Philip A Wolf; Ralph B D'Agostino; Joanne M Murabito; William B Kannel; Emelia J Benjamin
Journal:  Circulation       Date:  2003-05-27       Impact factor: 29.690

Review 8.  Thrombosis and antithrombotic therapy in women.

Authors:  Alison L Bailey; Dawn C Scantlebury; Susan S Smyth
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-02-16       Impact factor: 8.311

Review 9.  Antiplatelet and anticoagulation for patients with prosthetic heart valves.

Authors:  S H Little; D R Massel
Journal:  Cochrane Database Syst Rev       Date:  2003

10.  Neurological events during long-term mechanical circulatory support for heart failure: the Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) experience.

Authors:  Ronald M Lazar; Peter A Shapiro; Brian E Jaski; Michael K Parides; Robert C Bourge; John T Watson; Laura Damme; Walter Dembitsky; Jeffrey D Hosenpud; Lopa Gupta; Anita Tierney; Tonya Kraus; Yoshifumi Naka
Journal:  Circulation       Date:  2004-05-03       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.